PR-93

N/A

Report date: 2023/09/04 17:39:23

Base Information

Drug NamePR-93
Drug Alias NamePR-93PR93
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN replacements
TargetsPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTheraPten Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesTheraPten Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A